Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O et al. (2025)
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keaf016, PubMed 39775478

Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP, SENSCIS Trial Investigators (2024)
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Rheumatology (Oxford), 63 (3), 639-647
DOI 10.1093/rheumatology/kead280, PubMed 37294870

Andel PM, Aamodt AH, Gleditsch J, Melin E, Rootwelt-Revheim ME, Steine K, Atar D (2024)
Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life
Cardiology, 149 (6), 571-579
DOI 10.1159/000540007, PubMed 39025051